Romotal en es it fr

Romotal Brand names, Romotal Analogs

Romotal Brand Names Mixture

  • No information avaliable

Romotal Chemical_Formula


Romotal RX_link

Romotal fda sheet

Romotal msds (material safety sheet)

Romotal MSDS

Romotal Synthesis Reference

No information avaliable

Romotal Molecular Weight

198.264 g/mol

Romotal Melting Point

183.5 oC

Romotal H2O Solubility

217 mg/L

Romotal State


Romotal LogP


Romotal Dosage Forms

No information avaliable

Romotal Indication

For the treatment of mild to moderate dementia of the Alzheimer's type.

Romotal Pharmacology

Tacrine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. Tacrine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Tacrine is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, tacrine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. There is no evidence that tacrine alters the course of the underlying dementing process.

Romotal Absorption

Tacrine is rapidly absorbed. Absolute bioavailability of tacrine is approximately 17 ± 13%.

Romotal side effects and Toxicity

No information avaliable

Romotal Patient Information

No information avaliable

Romotal Organisms Affected

Humans and other mammals